The artificial intelligence start-up, which competes with OpenAI, is aiming to raise around $10 billion amid talk of a potential initial public offering. By Mike Isaac and Cade Metz Reporting from San ...

Drugmakers plan to raise U.S. prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster cancer treatment Ibrance, even as the Trump administration ...

The costs of at least 350 drugs in the U.S. are expected to rise in 2026, according to a new analysis, despite many of the drugmakers pledging to offer more favorable prices under new Trump ...

Drugmakers are reportedly preparing to raise U.S. prices on at least 350 branded medicines in 2026, including vaccines for COVID-19, RSV, and shingles, as well as major cancer therapies, despite ...

Tigress Financial raised the firm’s price target on Nvidia (NVDA) to $350 from $280 and keeps a Strong Buy rating on the shares, which the firm calls “the must-own core holding in the AI investment ...

SpaceX is kicking off a secondary share sale that would value the rocket maker at $800 billion, people familiar with the matter said, surpassing OpenAI to make it the most valuable U.S. private ...

The Lexus RX 350 was first introduced in the mid 2000s, when it replaced the RX300 as one of the very first crossover SUVs of all time. Over the past two and a half decades, the RX has gone through ...

President Trump on Thursday announced a deal to drastically lower the price of weight loss drugs for some Americans. "Today, I'm thrilled to announce that the two world's largest pharmaceutical ...

Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have access to them under two deals announced Thursday by the Trump administration.

ADVANCING MOST-FAVORED-NATION (MFN) PRICING: Today, President Donald J. Trump announced the latest in a series of the most significant actions ever taken by our Federal government to lower ...

Energy Transfer trades at the second-lowest valuation in its peer group. The MLP is in the strongest financial position in its history. It has lots more growth coming down the pipeline. As a result, ...

Considered by Royal Enfield to be the “cornerstone of its 124-year history as one of the company’s earliest and most popular bikes,” the iconic Bullet 350 finally made its way to North American shores ...